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Abstract

Pediatric sepsis is a major contributor to childhood morbidity and mortality. Tools for predicting
sepsis in pediatric patients have had poor predictive ability nor been validated. Risk assessment
screening tools are effective at earlier detection of sepsis. The implementation of an evidencebased pediatric sepsis screening tool could reduce time to detect and diagnose severe sepsis so
that patient treatment could occur earlier. This was a quality improvement project that evaluated
a sepsis screening tool predictive validity at a children’s hospital.
Keywords: sepsis, severe sepsis, screening tool, pediatric, child, risk assessment tool
Acknowledgements: The authors gratefully acknowledge the Children’s Hospital Association’s
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Final Defense: Sepsis Screening Tool Assessment at Helen DeVos Children’s Hospital
Pediatric sepsis is a major contributor to childhood morbidity and mortality (Schlapbach
& Kissoon, 2018). According to Weiss et al. (2015), there is an 8.2%prevalence of pediatric
severe sepsis in critically ill patients globally, with a hospital mortality rate of 25%. Despite
global recognition as a problem, unclear sepsis definitions prohibit bedside clinicians from
accurately identifying sepsis (Schlapbach & Kissoon, 2018). Tools for predicting sepsis in
pediatric patients have poor predictive ability nor can evidence be found in the literature that
they are validated. Systemic inflammatory response syndrome (SIRS) was used to define and
predict sepsis in pediatric patients (Schlapbach & Kissoon, 2018). However, this criterion had
low specificity and of limited use to clinicians (Schlapbach & Kissoon, 2018). An evidencebased pediatric sepsis screening tool is needed in order to initiate earlier diagnosis of sepsis and
decrease the number of sepsis cases per year. The purpose of this quality improvement project
was to assess and validate a pediatric sepsis screening tool in use at a freestanding children’s
hospital in the Midwest (that referred to as CHM).
Assessment of the Organizational
An organizational assessment (OA) is a systematic process intended to evaluate the
workflow and factors that affect the performance of an organization (Reflect & Learn, n.d.).
From an OA, the organization can better understand areas of competence and areas needing
improvement. The purpose of this OA was to analyze CHM using an OA framework. Primary
stakeholders were identified, and strengths, weaknesses, opportunities, and the threats (SWOT)
of the organization explored through a SWOT analysis.
Framework for Assessment
The Canadian Foundation for Healthcare Improvement (CFHI) assessment tool
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evaluates an organization’s capability for change, the strengths the organization possesses in
implementing change, and how the organization can expand these strengths for improvements
(CFHI, 2014). CFHI is guided by six core principles that were developed with the
goal of supporting healthcare improvement. These factors include patient-centered and
population-based care, evidence-based decision making, engaging a wide range of stakeholders,
engaging participation from managers and providers, using an incremental process for large scale
improvements, and viewing improvement as a collective learning process (CFHI, 2014).
Appendix A depicts how these factors equally contribute to overall healthcare improvement
(adapted from CFHI, 2018). The CFHI assessment tool analyzes how well organizations include
each criterion to form suggestions for care improvements within the organization.
CFHI recognizes that healthcare improvement requires collaboration from all levels of a
system, including policy, organizational, clinical, and front-line staff (CFHI, 2014). Furthermore,
CFHI also advises for operating in change cycles for improvements, rather than constant
reorganizing to maintain stability for the organization. Finally, CFHI holds the stance that
change within a level of a health system can lead to improvements at the clinical level, including
patient health outcomes and hospitalization experiences (CFHI, 2014).
Ethics and Protection of Human Subjects
CHM and the GVSU Institutional Review Boards (IRB) determined the project to be
quality improvement (see Appendix B and C).
Stakeholders
Key stakeholders are individuals affected by change within an organization, or
individuals who have an interest in the project outcome (Moran, Burson, & Conrad, 2017). For
the implementation of a pediatric sepsis screening tool at CHM, the key stakeholders were the
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healthcare providers i.e., physicians, physician assistants, nurse practitioners, and nurses.
Patients were also an important stakeholder, because patients are the highest priority when
implementing a change that affects patient outcomes. Other stakeholders included the sepsis
steering committee at CHM, and the electronic health record (EHR) technical employees who
worked to implement the chosen screening tool into the EHR. Finally, another key stakeholder
that is of importance to note is CHM as an organization. It was pertinent the organization
understood the importance of adding a pediatric screening tool, because there could have been a
monetary cost to adding the tool into the EHR.
SWOT
A SWOT analysis is a tool used to analyze strengths, weaknesses, opportunities, and
threats to a phenomenon of interest (Moran et al., 2017). Internal analyses include identifying
attributes and evaluating successes and weaknesses within the organization. External analysis
includes evaluating environmental influences and identifying opportunities or obstacles for the
phenomenon of interest (Moran et al., 2017). The phenomenon of interest for this SWOT
analysis was infection (sepsis). Appendix D displays the SWOT analysis discussed below.
Strengths. Strengths of CHM included their interprofessional collaboration as well as
utilization of a sepsis steering committee. Along with this, building on existing sepsis protocols
within the adult and neonatal populations aided in collaboration for this pediatric sepsis
screening tool. Finally, a strength of CHM was their ranking as one of the best children’s
hospitals in six specialty areas for 2018 by U.S. News and World Report (Jensen, 2018). This
shows what others perceive as CHM strengths, which is an important part of this analysis (Moran
et al., 2017).
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Weaknesses. Weaknesses of CHM included the current state of the pediatric sepsis
screening tool being on paper and not embedded in the EHR. This caused tension with RNs,
because it was an added task for the RNs to fill out a paper tool rather than within the EHR.
Another weakness was collating paper documents. It was time consuming to evaluate use of the
screening tool on paper compared to use in an EHR, which can generate a report. Furthermore, it
was difficult to ensure screening tools were timestamped correctly when on paper, if RNs did not
chart the exact time the screen was performed. Finally, the timing of the paper sepsis screening
tool was initiated shortly after a new EHR was initiated at CHM. This caused RN dissatisfaction,
confusion and errors, as RNs were overloaded with change. This led to a lack of proper screening
and/or proper documentation of sepsis screening.
Opportunities. One opportunity was the CHA sepsis collaborative. This is a
collaborative with other children’s hospitals works together to find the best solution for sepsis
screening. Another opportunity was the ability to work within the new EHR to initiate a tool
within the electronic documentation platform to screen for pediatric sepsis. The EHR in use at
CHM allows for creation and customization of tools and would support the pediatric sepsis
screening tool built within the EHR.
Threats. Threats to this project were deadlines. Part of the CHA collaborative requires
that data be entered by certain deadlines. The first deadline was October 1, 2018 when
retrospective data must be entered so that CHM could continue as a CHA collaborative member.
This was a difficult process at CHM, because retrospective data had to be retrieved from the
older version of the EHR, and there had been difficulty generating reports. Another threat to this
project was the rapid nature of the work being done without considering all the factors to create
change and be successful, such as the lack of an evidence-based tool used within CHM. Without
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evidence to support a tool, data collected may not be valid, which could threaten the work that
had been done at CHM.
Clinical Practice Question
The following clinical questions were addressed. “Did the current pediatric sepsis
screening tool in use at CHM identify patients at risk for sepsis?” As well as, “Did the sepsis
screening tool used initiate interventions (i.e. fluid boluses and antibiotics) earlier than when
compared to no tool being used?”
Review of the Literature
Method
Search methods. A comprehensive electronic search was conducted in the CINAHL,
PubMed, and Web of Science electronic databases and was limited to reviews in the English
language during the period of 2013 to 2018. Keywords were sepsis, tool, pediatric, neonate,
child, and early warning score.
Inclusion and exclusion criteria. The inclusion criterion for the literature review search
included articles that were published from 2013 to present. The type of studies included were
meta analyses, randomized control trials (RCTs), and systematic reviews. The search was also
limited to peer-reviewed journals. Exclusion criteria included clinical trials, pilot studies,
observational studies, and articles published greater than 5 years ago.
Population. Included were samples that featured sepsis populations in acute care
settings. For the purpose of this review, a pediatric population was defined as patients zero to 18
years of age, including the neonatal period (0-28 days). After limited research presented on
pediatric sepsis independently, articles that discussed adult sepsis protocols while acknowledging
pediatric differences were also included in this review.
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Intervention. Interventions for this literature review targeted sepsis screening tools in the
acute care setting. This excluded studies that only analyzed biomarkers or medication therapies
for the treatment or prevention of sepsis. Screening tools intended for use in outpatient settings
were excluded.
Comparison. The comparison group for this was pediatric acute care settings that did not
utilize a pediatric sepsis screening tool. This included settings that utilized an adult sepsis
screening tool on a pediatric population. Also included were pediatric sepsis screening tools in
use that were not supported by an evidence-base.
Outcome. The intended outcome was increased early identification of pediatric sepsis. In
time, this could lead to decreased morbidity and mortality rates caused by pediatric sepsis. This
also, could lead to increased quality of life outcomes for survivors of pediatric sepsis. Currently,
17% of pediatric sepsis survivors globally have at least moderate disability after surviving sepsis
(Weiss et al., 2015).
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)
guideline served as the framework for this review (Moher et al., 2015). The search initially
yielded 243 CINAHL, PubMed, and Web of Science articles. Nine duplicates were found, with
234 articles remaining. Each paper was screened using inclusion and exclusion criteria according
to PRISMA criteria (Moher et al., 2015) (see Appendix E). Review of titles and abstracts
resulted in removal of 214 articles that did not meet the inclusion criteria. An additional 16
articles were excluded after in-depth examination of content, as did not meet inclusion criteria.
The remaining four articles were included in this review.
Summary of Results
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Four papers met inclusion criteria and were included in the review (see Appendix F).
These four studies included three systematic reviews and one RCT.
Study characteristics. Three of the articles were conducted in the United States (Davis
et al., 2017; Lake, Fairchild, & Moorman, 2014; & Roney et al., 2015 and one in Australia
(Paliwoda & New, 2015). All of the studies took place in the acute care hospital setting. One
article examined heart rate activity in neonatal infants as a marker for neonatal sepsis (Lake,
Fairchild, & Moorman, 2014). The other three articles systematically reviewed sepsis protocol
screening tools for the neonatal, pediatric, and adult populations (Davis et al., 2017; Roney et al.,
2015; & Paliwoda & New, 2015). All of the studies involved analysis of screening for earlier
identification of sepsis.
Intervention and comparison characteristics. Each of the reviews reported on efficacy
of screening for sepsis and protocol to identify sepsis-based articles within each review’s
inclusion criteria (Davis et al., 2017; Roney et al., 2015; & Paliwoda & New, 2015). One review
evaluated a sepsis screening tool based on mortality predictive value and/or reduction,
emergency calls, and utilization of a rapid response team (Roney et al., 2015). Another compared
neonates whom received an intervention based upon use of a sepsis screening tool (Paliwoda &
New, 2015). The third compared previous sepsis guidelines to more recent quality improvement
initiatives to identify sepsis sooner (Davis et al., 2017). The RCT compared heart rate
characteristics (HRC) of neonates with and without confirmed sepsis (Lake, Fairchild, &
Moorman, 2014).
Measures. A variety of outcome measures were used. The outcomes in the systematic
reviews were earlier identification of patient deterioration and decreased time to intervention
(Davis et al., 2017; Roney et al., 2015; & Paliwoda & New, 2015). The RCT measured risk
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markers for proof of improved clinical outcomes, such as analyzing HRC as a predictor for
sepsis development and how much monitoring HRC improves clinical outcomes for septic
neonates by means of analyzing mortality rate (Lake, Fairchild, & Moorman, 2014).
Efficacy of earlier identification and decreased time to intervention. Earlier
identification of patient deterioration had variation in measures within each review. One review
found use of the modified early warning scoring (MEWS) screening tool effectively detected
earlier identification of sepsis as evidenced by a significant rate in mortality reduction (Roney et
al., 2015). This review also analyzed MEWS effectiveness for early sepsis identification by a
decrease in rapid response team utilization. Davis et al. (2017) also discussed efficacy of a tool
by analyzing mortality rate. This review found after initiating a trigger tool for sepsis, mortality
rates decreased for both the pediatric and neonatal populations. One study within the review
discussed a mortality rates decreased from 38% to 8% after initiating the sepsis tool. Another
study discussed within this review had a mortality rate decrease from 20% to 7% (Davis et al.,
2017). After performing a systematic review on early warning tools (EWTs) Paliwoda and New
(2015) applied the new tool (EWT) to old charts of children who were identified with pediatric
sepsis. As a result of the EWT, 47% of neonates would have received an intervention for sepsis
(Paliwoda & New, 2015).
Efficacy of HRC risk markers. Lake, Fairchild, and Moorman (2014) discussed risk
markers for proof of improved clinical outcomes. To detect predictive values of sepsis risk,
antibiotic initiation and use in neonates with and without HRC monitoring were analyzed. The
RCT looked at mortality rate differences between use or non-use of the HRC, and the mortality
rate decreased in the HRC use group from 10.2% to 8.1% (p=0.04). Furthermore, in low birth
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weight neonates, the mortality rate decreased from 17.6 to 13.2% (p < 0.02) with use of HRC
monitoring (Lake, Fairchild, & Moorman, 2014).
Evidence for Project
Findings of this review suggested use of a screening tool for earlier identification and
initiation of interventions for pediatric sepsis improved patient outcomes. Factors to be included
in a sepsis screening tool include respiratory rate, heart rate, blood pressure, temperature
(specifically hypothermia or hyperthermia), altered mental status, and capillary refill (Davis et
al., 2017; & Roney et al., 2015). Furthermore, it was suggested that neonates have more specific
criteria for the screening tool, such as HRC, glucose level, and behavioral monitoring (e.g.,
lethargy or poor feeding) (Paliwoda & New, 2015; & Lake, Fairchild, & Moorman, 2014).
In addition to the neonatal population, units treating a specific type of pediatric patient
population should have more specific criteria for the particular sub-population (Roney et al.,
2015). For example, pediatric oncology/hematology patients may have indicators or a narrower
index for the criteria listed above when screening for sepsis than the general pediatric population.
This is under development and needs additional research (Roney et al., 2015).
There are limitations specific to the review that warrant discussion. First, as sepsis is an
ever-evolving topic, there was limited data in the past 5 years regarding reliability and validity of
pediatric sepsis screening tools. The studies in this review had small sample sizes and similar
criterion. However, no standardized pediatric sepsis screening tools were used in the four studies.
Although this is more of a limitation of current research rather than a reflection of this review.
Pediatric sepsis is a significant problem that often leads to devastating outcomes. Earlier
identification and intervention may be a solution. Without use of an evidence-based pediatric
sepsis screening tool, early signs of sepsis in this population are often missed. This review
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highlighted pediatric sepsis screening tools as an efficacious approach to earlier identification of
sepsis.
Results suggest that the current evidence is in favor of utilizing a screening tool for sepsis
designed for use within the pediatric population as a gold standard for clinical practice in the
acute care hospital setting. Use of this type of tool has the potential to improve patient outcomes
and reduce mortality rates in the pediatric population.
Phenomenon Conceptual Model
Conceptual models are useful as guides for understanding a phenomenon. The
phenomenon of interest for this quality improvement project was infection, more specifically
sepsis. A conceptual model that was used to provide structure for this phenomenon of interest is
the Center for Disease Control and Prevention (CDC) Infectious Disease Framework (IDF)
(CDC, 2011). IDF is broken down into three elements that guide the process of disease
prevention (see Appendix G). The model was designed to provide a map for improving and
preventing infectious diseases. The IDF also acts as a guide for creating evidence-based policies
(CDC, 2011).
Element one. The first element of IDF focuses on strengthening public health
fundamentals, including surveillance of infectious disease (CDC, 2011). Surveillance of
infectious disease drives public health actions. As suggested by the first element of IDF,
surveillance can lead to the advancement of workforce development to prevent infectious
diseases by improving knowledge on sepsis and improving earlier detection of sepsis (CDC,
2011).
Element two. The second element of IDF builds upon the first, in that it discusses
implementation of interventions to reduce infectious diseases (CDC, 2011). This element
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specifically discussed identifying and validating tools for disease reduction. This is what the
foundation of this project was built upon; validating a sepsis risk assessment tool in order to
reduce high-burden infectious diseases through earlier identification (CDC, 2011).
Element three. Finally, the third element of IDF focuses on developing policies to
prevent, detect, and control infectious diseases (CDC, 2011). Validating a sepsis risk assessment
tool covers the prevention aspect of this element, because it aligns with the CDC’s position of
evidence-based detection policies. However, controlling this type of infectious disease is a step
beyond what this specific project covered. Beyond this project, policies can be developed and
implemented within CHM based on evidence. This could include a sepsis bundle for initiation of
interventions once sepsis is diagnosed.
Project Plan
Purpose of Project and Objectives
The overarching goal of the project was to improve pediatric sepsis detection using a
screening tool. The current tool used at CHM underwent expert review, thus, it had content
validity. Construct validity to determine if the screening tool detects sepsis never occurred. Thus,
the project examined if the sepsis screening tool would detect risk of sepsis.
Design for the Evidence-based Initiative
This project was a quality improvement project focused on tool examination to validate
the sepsis screening tool effectiveness at predicting and identifying risk of sepsis. The project
also examined if use of the screening tool improved time to treatment (i.e. fluid boluses and
antibiotics) in those with a sepsis diagnosis compared to when no tool was used.
Quality improvement projects involve systematic activities designed to monitor, assess,
and/or improve an organization’s quality of healthcare (Health Resources and Services
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Administration, 2011). To examine if the screening tool detected risk of sepsis, a cohort of
patients diagnosed with sepsis were examined using the current sepsis screening tool just prior to
the patient demonstrating signs of sepsis. To examine time to intervention (i.e. fluid boluses and
antibiotics), the actual time administered was examined in those who used the screening tool
then compared to those who did not use the screening tool.
Setting
The setting for this project was a freestanding children’s hospital in the Midwest (CHM).
This included units with specialties in hematology, oncology, cardiology, respiratory, surgical,
and behavioral health. Administrative approval to conduct the project was obtained from the
organization (see Appendix H).
Participants
Patients with a diagnosis of severe sepsis in the hematology, oncology, cardiology,
respiratory, surgical, or behavioral health units were included. The sample size was 122 patients
to examine the detection of risk; and 167 to examine time to intervention (122 with no screening
tool and 45 with a screening tool).
Model Guiding Implementation
The model guiding implementation of this project was the Institute for Healthcare
Improvement (IHI) Plan Do Study Act (PDSA) cycle (see Appendix I). This model is useful for
documenting and testing a proposed change (IHI, 2017). At CHM, the PDSA model is well
recognized and used, which was a big draw for using it within the context of this project.
Plan. The plan phase of PDSA includes stating the question and a prediction for what
will happen, developing a plan to test the change, and identifying what data needs to be collected
(IHI, 2017). The clinical question was, as previously discussed, “Did the current pediatric sepsis
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screening tool in use at CHM identify patients at risk for sepsis?” As well as, “Did the sepsis
screening tool used initiate interventions (i.e. fluid boluses and antibiotics) earlier than when
compared to no tool being used?” A prediction for what will happen was that time to detection of
sepsis will be quicker with use of this tool and better overall sepsis outcomes will ensue. A plan
was developed to validate the screening tool for sepsis included analyzing patient charts of those
diagnosed with severe sepsis to determine predictive ability of the tool. Identification of data
collected is discussed within the measures section of the paper.
Do. The next step of PDSA is the do stage. During this stage, a test is carried out on a
small scale with data collection and analysis (IHI, 2017). This phase was carried out by
performing a small 5-chart audit of pre-tool patients diagnosed with severe sepsis. This small
sample provided data to discover the amount of time needed to perform a chart audit in order to
determine a sample size for the tool validation, with over 100 charts likely to be needed for
statistical models to examine validity.
Study. During the study phase of PDSA, results are analyzed and compared to original
predictions (IHI, 2017). After deciding on a sample size, the chart audits occurred on patients
both before implementation of current tool and after tool was implemented at CHM of patients
with diagnoses of severe sepsis. During this phase, data were analyzed to determine if the current
tool at CHM detected sepsis risk or not.
Act. In this stage of PDSA a decision has to be made to adapt, adopt, or abandon the
change before starting a new cycle in the plan phase of PDSA (IHI, 2017). Adapting the change
involves making modifications and running another test. Adopting the change involves testing
the change on a larger scale. Abandoning the change involves changing the idea altogether (IHI,
2017). The anticipated outcome was that during this phase CHM would be adopting the change.
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Implementation Steps and Strategies
According to Powell et al. (2015), there are evidenced-based implementation strategies to
be used within the implementation of a project. Each will be discussed.
Readiness assessment and identify barriers. First, a strategy that was used within the
context of this project was assessment of readiness and identifying barriers to the project (Powell
et al., 2015). This was conducted during the organizational assessment and SWOT analysis. The
assessment discovered implementation strategies in place that further assisted with this project.
Capturing and sharing knowledge and creating a collaborative. These strategies
included capturing and sharing knowledge, creating a learning collaborative, organizing
implementation team meetings, and using an implementation advisor (Powell et al., 2015).
Capturing and sharing knowledge, as well as creating a learning collaborative, are both aspects
of ongoing implementation strategies at CHM. CHM is part of a greater sepsis collaborative put
on by the Children’s Hospital Association (CHA). This collaborative has a goal of reducing
hospital-acquired severe sepsis and sepsis mortality by 75% by the year 2020 (CHA, 2018). By
joining this collaborative, CHM became part of an all-teach, all-learn interdisciplinary team
which allowed them to view current research other hospitals are doing in order to see what is
working for them. After joining this collaborative, CHM also created a sepsis steering committee
to work as the driving force for the organization; this fulfilled the implementation strategy of
organizing a team and team meetings (Powell et al., 2015). Finally, this committee appointed an
implementation advisor to direct the group meetings.
Consultation and tools for quality improvement. Beyond these initial strategies
already in place, the project purposely re-examined the implementation, provided ongoing
consultation, and developed tools for quality monitoring (Powell et al., 2015). Purposely re-
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examining the implementation of a risk-assessment tool took place by the DNP student, because
CHM initially implemented the risk assessment tool without first ensuring it was evidence-based.
Next, the DNP student provided ongoing consultation with CHM based on findings in literature
and work found through chart audits to validate the risk assessment tool. Finally, the DNP
student developed tools for quality monitoring through a table of measures and codebook used to
conduct chart audits.
Measures
Measures for gauging the project success included system and pediatric patient
measures. System measures were admission to ICU, time to admit to ICU after diagnosis, time to
antibiotic initiation, time to fluid bolus, time to “trigger” tool, and time to sepsis huddle. The
patient measures were tachycardia, bradycardia, hypotension, fever, hypothermia, current use of
steroids, altered mental status, the presence of chills, capillary refill greater than 3 seconds,
mottled or cool extremities, presence of neck stiffness, “flash” capillary refill less than 1 second,
and presence of neutropenia (ANC less than 500). Definitions for each measure are shown in
Appendix J and K. A flow chart further defining triggers that prompt measurement is shown in
Appendix L.
Items on the screening tool for sepsis were selected by CHM based on information from
the CHA (2018) sepsis collaborative. To assure screening tool items were evidence based,
literature supporting each item on the tool are shown in Appendix M. In addition, content experts
from the CHM sepsis steering committee reviewed each item on the tool and reconfirmed usage.
Data Collection Procedures
Data were collected by the DNP student through chart reviews in the EHR as described in
Appendix J (January 1, 2017 through August 31, 2018). CHM changed to a new EHR in
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November of 2017 thus, data prior to that date were from the old platform. Data were collected
from patients who had a diagnosis of severe sepsis. This included the old EHR dates of January
1, 2017 through October 31, 2017 and new EHR dates of November 1, 2018 through August 31,
2018. Data were kept on a secure network password protected internal drive at the site,
accessible by members on the team from CHM.
Data Management
First, data were collected from the EHR in an Excel datasheet stored on the CHM internal
drive. Next, data in the excel datasheet was de-identified. After de-identified, the student and
biostatistician analyzed the data using Statistical Analysis System (SAS) version 9.4 (statistical
software).
Analysis
Data were analyzed using factor analysis (shown below) to determine if the screening
tool detected sepsis prior to the sepsis diagnosis. For time to intervention, a pre- and post-tool
comparison provided data on if time to intervention improved after initiation of screening tool
usage used t-test or chi-square, with a p-Value of 0.05 demonstrating a difference.
Factor analysis. A plan was devised to use factor loading of the following variables: did
patient go to ICU, time to ICU, time to antibiotic initiation, time to fluid bolus, time to “trigger”
tool, time to sepsis huddle, and presence of tachycardia, bradycardia, hypotension, fever,
hypothermia, current use of steroids, altered mental status, chills, capillary refill greater than 3
seconds, mottled or cool extremities, neck stiffness, "flash" capillary refill less than 1 second, or
neutropenia was conducted. Construct validity testing of the unidimensionality of the risk of
sepsis variables using structural equation modeling (SEM) techniques of exploratory factor
analysis (EFA) and confirmatory factor analysis (CFA) with principal axis factoring varimax
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(orthogonal) rotation was assessed. SEM is an analytical tool that provides an alternative to
experimentation for examining the plausibility of hypothesized models (Kline, 2005). Missing
data were checked and corrected if possible, otherwise cases with missing data were removed
prior to analysis. Random assignment to two datasets occurred splitting data in half, one half
used for EFA and the other CFA. Cross-validation of a dataset strengthened predictive validity
(Vandenberg, 2006).
Exploratory analysis. Sampling adequacy tests was done using the Kaiser-Meyer-Olkin
(KMO) and Bartlett test. KMO is a measure of sampling adequacy comparing the magnitudes of
the observed correlations coefficients to the correlation coefficients, which should be greater
than .50 for a satisfactory factor analysis to proceed (Kline, 2005). Bartlett is an indicator of the
strength of the relationship among variables testing if the correlation matrix is uncorrelated and
whether the correlation matrix is an identity matrix; a significance level must be small enough to
conclude that the association of the relationship among the variables is strong (Kline, 2005). If
significant then the correlation matrix is not an identity matrix, structure exists and the strength
of the relationship among the variables is large enough for factor analysis (Kline, 2005).
Confirmatory analysis. A two-step approach was taken, testing the measurement model
for fit before testing the full structural model (Joreskog & Sorbom, 2004). Two indictors were
used to examine CFA: comparative fit index (CFI), a relative fit index with values ≥ .95
indicating good fit; and the root mean square error of approximation (RMSEA), an indicator of
the discrepancy in fit per degree of freedom adjusted for sample size, with values smaller than
0.08 providing a reasonable approximation of the factor loading (Kline, 2005). If the model
converges, and the fitting measures indicated a good fit (RMSEA; CFI), confirmation of a
relationship will exist.
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Resources & Budget
Resources for this project included the DNP student, the sepsis steering committee,
clinicians, and RNs. Further resources for this project included organizational support such as the
facility itself, computers, and the ability to print the pediatric sepsis paper tools. The DNP
scholarly project to validate the sepsis screening tool included a budget (see Appendix N). The
DNP student filled a need for the organization at no cost other than use of staff time to provide
information or data related to the project. The site staff involved in this project had approved
time to put towards this project as part of their roles.
Timeline
Institutional Review Board (IRB) approvals were obtained from the site and university.
The groundwork (i.e. performing an organizational assessment and completing a literature
review) for the project was completed on July 28, 2018. The project proposal took place on
November 7, 2018. Upon approval, data collection began and was collected through February 1,
2019 followed by data analysis. Findings were disseminated to key stakeholders by March 4,
2019. The final project defense took place on April 8, 2019. The time line for this project is
shown in Appendix O.
Results
Descriptive statistics were run and a pre- and post-tool comparison were utilized to
provide data to determine if time to intervention improved after initiation of screening tool usage
using t-test or chi-square, with a p-value of 0.05 demonstrating a difference were used as SEM
was found to be insufficient.
Patient Characteristics
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The characteristics of patients in the audit are shown in Appendix P. Mean age was
7.05(SD 6.05) years with a range of 0.02-20.57. There were nearly even numbers of males
(55.7%; n = 93) and females (44.3%; n = 74); most were Caucasian (60.5%; n = 101) or African
American (6.2%; n = 27); and 13.8% (23) were Hispanic. Length of stay was a median of 10.5
(IQR 4.94 –19.14) and 6% (n = 10) had hospital acquired sepsis.
Audit of Clinically Derived Time Zero (CDTZ)
Patients audited during data collection all had a Clinically Derived Time Zero (CDTZ) –
this was determined by a physician within the organization who retrospectively determined the
time when each patient first showed signs of severe sepsis. CDTZ acted as “time zero” for
determining the length of time it took for fluid, antibiotics, and transfer to ICU to be initiated.
CDTZ also acted as the last point where the sepsis screening tool should have flagged in order to
be still considered “screening” for the detection of sepsis.
Overall 71.7% (n = 119) would have flagged within 24 hours. Of these patients, 34.8%
(58) would have flagged before or at CDTZ. However, 28.3% (n = 47) of patients would not
have flagged within 24 hours of clinically derived time zero using the tool (see Appendix Q).
Frequency of High-Risk Factors
The sepsis screening tool took into account certain high-risk factors to be considered
when screening patients for sepsis. These factors would not in and of themselves flag the tool but
having high-risk factors in addition to flagging steps 1 and 2 on the tool would initiate a call for a
provider to come assess the patient.
Of the high-risk factors evaluated, when the factor occurred, documentation was not
always easily found in the audit (see Appendix R). For example, “Leukopenia, Leukocytosis, or
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Bands >10% in the last 12 hours” was only credited if the labs were documented before or at
clinically derived time zero. If labs were drawn after CDTZ of sepsis, it was considered as not an
early enough indicator to flag the tool. Further, it was difficult to document “no” for a high-risk
factor unless it specifically stated somewhere within a patient’s chart that they patient did not
have the factor. For example, not a single chart specifically stated that a patient “did not” have
asplenia. Due to this, all patients were considered “not documented/unclear” besides the 2 whose
chart explicitly stated they did have asplenia. This was a common problem in auditing the highrisk factors of where to find in the chart an actual documentation of the risk factor.
Abnormal High-Risk Condition: ANC
A particular high-risk factor added for immunocompromised patients was calculating of
the ANC. The ANC was specifically analyzed in relation to being less than 500 for greater than 7
days. For the purpose of this analysis, ANC below 500 in and of itself was analyzed as a highrisk factor, regardless of the number of days it had been present. As shown in Appendix S, of the
times an ANC value (N = 47) was calculated, the median 35.57, was below 500.
Time from Status Change to ICU admission, Antibiotic, and Fluid initiation
Appendix T shows a decrease in median time to patient transfer to ICU (2.24) and fluid
administration (0.17), while time to antibiotic treatment increased (0.29). There was not
sufficient evidence to say that time SEPSIS was flagged improved when comparing before to
after tool use (p=0.19).
Clinical Status Symptom/Sign that Flagged the Tool
As shown in Appendix U, the top five clinical status symptoms/signs that flagged the tool
were tachycardia (65.3%, n = 109), fever (62.9%, n = 105), altered mental status (38.9%, n =
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65), capillary refill greater than 3 seconds (18.6%, n = 31), and hypothermia (18.0%, n = 30).
Mottled and/or cool extremities and neutropenia were also above 10% occurrence.
Age Range Parameters
Appendix V shows the mean or IQR for heartrate, fever, and blood pressure by age
groups and should be interpreted within the parameters expected of each age group. For example,
the mean heart rate for >1 – 2 months and 3 – 11 months did not meet parameters for sepsis
criteria. Furthermore, no age group had an average systolic blood pressure that would have met
the criteria for that age group. It also is important to note that diastolic values were used for the
purpose of this calculation, but the tool did not have parameters for the diastolic blood pressure
values.
Factors that Flagged the Tool Before- or At- CDTZ
As shown in Appendix W and X, the top five clinical status high risk factors that flagged
the tool before or at clinically derived time zero were tachycardia (84.5%, n = 49), fever (79.3%,
n = 46), altered mental status (65.5%, n = 38), CNS dysfunction (51.7%, n = 30), and presence of
a central line (36.3%, n = 21). Capillary refill greater than 3 seconds, leukopenia leukocytosis
Bands >10% in the last 12 hours, hypotension, and hypothermia were also above the 20%
occurrence rate.
Discussion
Current State
This project found that the current tool use at CHM to detect risk of sepsis needs further
examination of validity and reliability. This is supported by the current state of the literature in
that no evidence-based sepsis screening tools are tailored for pediatric populations, as only
content-reviewed factors to screen for when evaluating for sepsis in pediatrics (Davis et al.,
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2017; Lake, Fairchild, & Moorman, 2014; Paliwoda & New, 2015 & Roney et al., 2015). As
there are no other tool, the creation and testing of a tool to detect risk of Sepsis is needed before
a tool will be validated for evidence-based use.
Key Findings
Although the anticipated outcome of tool construct validation was not met, there were
several strengths found within this project. First, this is a much-needed area of study and any
research findings to add to the current state of literature aid in shaping future tool validation.
Second, a decrease in median time to ICU transfer and fluid bolus initiation were found when
comparing pre- to post- tool implementation. This shows an improvement in a critical timesensitive component of treating sepsis that is dependent on initially detecting sepsis through a
screening tool. Thirdly, this study spoke to what the top clinical status signs/symptoms were in
severe sepsis patients, this is useful information when deciding where to go next in configuring a
tool that has construct validity. Finally, this project also was able to evaluate age-specific
parameters for clinical status signs/symptoms such as heart rate, fever, and blood pressure. This
information is also useful when determining next steps for a sepsis screening tool and could be
used in future research.
Limitations
This project had a fairly short implementation period and small sample size. Although 20
months of data were used, there were still only 167 patients that met criteria of a severe sepsis
diagnosis included in this project. Due to this, SEM analysis was not able to be performed, which
could have been an advantageous statistical analysis to run for this type of project. Another
limitation is the relatively small sample size of post-tool implementation patients (n=45). Time
constraints for data collection, as well as not enough collated data on severe sepsis diagnosed
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patients led to this smaller sample size. Another limitation was the lack of current evidence in
literature to support any pediatric sepsis screening tool, let alone this specific tool. Finally, it is
important to note that this project took place during a transition period from one EHR to another.
Therefore, it is possible that different results could ensue as time goes on with longer EHR use as
some results could have been due to a lack of understanding on how and where to properly chart
assessments within the EHR.
Implications for Practice and Further Study in the Field
As previously discussed, the top five clinical status that flagged the tool were
tachycardia, fever, altered mental status, capillary refill greater than 3 seconds, and hypothermia.
These factors appear to be the most useful in identifying pediatric sepsis and perhaps another
trial on a sepsis screening tool with these specific factors laid out in a different step-wise
configuration would be worth analyzing. For example, step 2 (related to temperature of the
patient) of the tool was often the last to flag. Thus, it may be worth reconsidering what factors
are analyzed within step 2 of the tool or even worth considering combining step 2 and 3 of the
tool into one category and then only enlisting a two-step function to flag the tool. It is also
possible that a temperature was not taken frequently enough on patients; if this is the case than
revisiting nursing assessment protocols for temperature frequency or critical thinking skills
related to when obtaining a temperature is indicated may need to be discussed.
Additionally, further exploration of the age-specific parameters for vitals needed to flag
the tool is needed. Specifically, definitions of hypotension in all age groups and heartrate in
infants less than one year should be considered. Another indicator that may need to be
additionally added to a pediatric sepsis screening tool is evaluating both systolic and diastolic
blood pressure values, and not only systolic values as the current tool does. Another indicator
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that a future study may want to evaluate is respirations per minute, peripheral capillary oxygen
saturation (Sp02), and/or hypertension. These were values that were often noticed outside of
normal parameters on patients, although they were not values collected or evaluated by the
current sepsis screening tool.
Another aspect to consider in future studies is a better definition of Central Nervous
System (CNS) dysfunction. This is a high-risk factor on the current screening tool that was found
to be in the top 5 indicators of patients that flagged the tool before or at CDTZ. It may be worth
considering redefining assessment standards for this patient population, as well as defining how
these patients exhibit altered mental status compared to patients without CNS dysfunction.
Finally, a future project may consider combining risk assessment tools in the pediatric
population into one cohesive tool. Currently at CHM there are several pediatric screening tools
that assess for different problems, however, many of them have overlapping factors being
assessed. It may be worth considering a way to combine these tools into one seamless tool that
would have an algorithm to delineate which illness is detected based on the clinical status
signs/symptoms found.
Dissemination of Results
Outcomes of this project were disseminated. First, tools for quality monitoring (table of
measures and codebook used to conduct chart audits) and findings were distributed to CHM at
the end of the project for use within the organization and collaborative. Second, findings were
presented at the student’s oral defense on April 8, 2019. Third, the final project defense paper
was posted on Scholarworks and can be accessed by anyone who is interested. Fourth, findings
will be presented at the organization’s research council poster presentation on April 9, 2019.
Fifth, findings will be presented to the sepsis steering committee at their May 6, 2019 meeting.
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Sustainability Plan

Sustainability of this DNP project included the following. First, the sepsis steering
committee chair will continue to monitor the effectiveness of the screening tool after the
completion of this project. Second, the sepsis screening tool was embedded into the EHR at
CHM on January 3, 2019 and will no longer be used as a paper tool, which makes for easier
monitoring of tool effectiveness and sepsis detection. This should also increase RN compliance
and morale towards the tool, because this eliminated the need for an extra step outside of
electronic charting. A new policy will not be needed at CHM. However, a new build was needed
in order for the screening tool for sepsis to be embedded into the EHR. This required IT
involvement with the EHR company, as well as assistance from the CHA collaborative. The
process for this new construct to be built into the EHR was completed as previously stated on
January 3, 2019 making ongoing monitoring of this tool easier at CHM.
Conclusion
CHM sought to validate a sepsis screening tool currently in use for evidence-based use.
An organizational assessment of the current policy and practice surrounding use of the sepsis
screening tool combined with a literature review on sepsis screening tools, identified the current
sepsis screening tool had content validity but still needed construct validity. Two theoretical
frameworks and one theoretical model were used to understand the phenomenon and conduct a
plan to validate the sepsis screening tool. Pre- and post-tool chart audits were performed to
implement this tool validation plan. Data collection occurred over two months including patients
from January 2017 through August 2018. Despite being unable to provide construct validity for
this pediatric sepsis screening tool, individual factors within the tool were able to be evaluated
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and future studies should build upon this research in order to work towards validating a pediatric
sepsis screening tool for evidence-based use.
Reflection on DNP Essentials
The American Colleges of Nursing (AACN) requires proficiency from DNP students in
the following 8 competencies which make up the foundation for advanced practice nursing roles.
Each are reviewed below.
Essential I: Scientific Underpinnings for Practice
The DNP can integrate science using science-based theories and concepts to determine
the significance of phenomena, as well as develop and evaluate outcomes of new practices based
on evidence to alleviate or enhance the phenomena (AACN, 2006). This essential was achieved
through this project by performing a literature review and using the knowledge gained from this
review to improve care. Additionally, frameworks were utilized for implementing and guiding
change.
Essential II: Organizational and Systems Leadership
The DNP can develop and evaluate care delivery approaches that meet the needs of
patient populations based on evidence-based findings in nursing science and other clinical
sciences (AACN, 2006). This essential was achieved through this project by evaluating a tool
that enhances care provided to the pediatric population. Furthermore, developing and evaluating
cost-effectiveness is another aspect of this essential that was met by developing a budget for this
project and monitoring the project’s cost effectiveness.
Essential III: Clinical Scholarship and Analytical Methods for Evidence-Based Practice
The DNP can translate research into evidence-based practice through use of analytical
methods to appraise existing literature, designing and implementing processes to evaluate
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outcomes of practice, and apply relevant findings to develop and improve practice guidelines
(AACN, 2006). This essential was achieved through this project by using analytic methods to
evaluate literature regarding the best evidence for sepsis screening in pediatric populations. The
project included designing a process to evaluate the effectiveness of the current sepsis screening
tool in place. Furthermore, relevant findings were disseminated to improve practice guidelines
for use of the tool.
Essential IV: Information Systems Technology
The DNP is proficient in use of and evaluation of information systems technology
resources to support practice and care. This includes related ethical, regulatory, and legal issues
related to use of information and systems technology (AACN, 2006). Through this project, this
essential was met by utilizing and navigating two different EHRs to gather pre- and post-tool
data. E-mail was used for communication with key stakeholders for progress updates and
additional resources. Excel was used for organizing and analyzing data. Strict confidentiality of
any identifiable patient data was maintained, and all ethical guidelines were followed during the
course of this project.
Essential V: Advocacy for Health Care Policy
The DNP critically analyzes health policy proposals, demonstrates leadership in the
development and implementation of policies, as well as educates and advocates for the nursing
profession (AACN, 2006). Although no formal policy was changed through this project,
education and advocacy for implementation of evidence-based policies at an organizational level
were performed through this project. Additionally, this essential was met through attendance of
Advocacy Day and meeting with state legislatures regarding policies that advocate for the
expansion of the advanced practice registered nurse role.
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Essential VI: Interprofessional Collaboration
The DNP exhibits leadership in collaborating between multiple healthcare specialties to
create change in complex healthcare delivery systems (AACN, 2006). This essential was met
through collaborating with multiple different healthcare roles in the development,
implementation, and evaluation of this project. Collaborative healthcare professionals included
RNs, managers, CNSs, educators, pharmacists, providers, IT/quality improvement data
specialists, and statisticians. Incorporating a diverse collaborative group allowed for better
understanding of the current practice, assessing barriers, and evaluating necessary practice
changes.
Essential VII: Clinical Prevention and Population Health
The DNP can analyze scientific data, synthesize concepts, develop/implement/evaluate
interventions, and address gaps in care related to clinical prevention and population health
(AACN, 2006). This project was focused on prevention for better population health. Sepsis is a
leading cause of hospital-related deaths – this not only causes poor patient outcomes but also
costs both the patient and the healthcare system substantial amounts of money. Validating a tool
in use to ensure it is actually detecting sepsis rates sooner allows the hospital to evaluate how
well they are doing with detecting and treating sepsis in their patients.
Essential VIII: Advanced Nursing Practice
This essential encompasses the competencies that are necessary for all DNP-prepared
specialties and act as a foundation for DNP practice. The DNP can: conduct comprehensive and
systematic assessments in complex situations; design, implement and evaluate interventions;
develop and sustain relationships with patients and other professionals in order to provide
optimal care outcomes; and demonstrate systems thinking in order to improve patient outcomes
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(AACN, 2006). This project covered all of these competencies. An organizational assessment of
current practice was performed and systems thinking was used to design and implement a plan to
evaluate the sepsis screening tool for evidence-based use. In order to carry out this project, many
relationships with various stakeholders, primarily consisting of the sepsis steering committee
members, were developed and sustained.
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Appendices
Appendix A

Engage front-line
managers and
providers
Promoting
evidence-based
decision-making

Focusing on
population needs

HEALTHCARE
IMPROVEMENT

Creating
supportive policies
and incentives

Engaging patients

Building
organizational
capacity

Appendix A. The Canadian Foundation for Healthcare Improvement Model
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Appendix B
Project Organization IRB Determination Letter

Appendix B. Available upon request.
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Appendix C
GVSU IRB Determination Letter
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Appendix D

•
•
•
•
•

•
•
•

Strengths
Interprofessional Collaboration
Sepsis Steering Committee
Collaboration with CHA
Collaboration within the organization of
CHM in other populations (i.e. adult and
neonatal)
Best Children’s Hospital in 6 specialty
areas for 2018

Opportunities
CHA sepsis collaborative
Working alongside new EHR to
implement a clinical decision support tool
within the EHR
Customization options within the new
EHR

•
•
•
•
•

•
•
•

Weaknesses
Current paper screening tool
Tension with RNs over adding another
task
Collating paper documents in order to
generate reports
Inaccurate timestamp on paper tool
RN confusion and increased errors related
to many changes occurring at once

Threats
Deadlines within CHA collaborative
Difficulty retrieving data from old EHR at
CHM
Current lack of evidence to support a
pediatric sepsis screening tool

Appendix D. SWOT Analysis of the Pediatric Sepsis Screening Tool at CHM.
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Articles identified using
keywords in CINAHL,
PubMed, and Web of
Science (N=243)

Eligibility

# of records screened
after 9 duplicates were
removed (n=234)

Full-text articles
assessed for eligibility
(n=20)

Included

Screening

Identification

Appendix E

Studies included in
this review (n=4)

Appendix E. PRISMA Flow diagram of search selection process.

Records excluded after
title and abstract
reviewed due to not
published in the past 5
years or article not
directly related to sepsis
screening (n=214)
Full-text articles
excluded for reasons
pertaining to population,
intervention,
comparison, and
outcome (n=16)
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Appendix F

Author (Year)
Purpose

Design (N)

Inclusion
Criteria

Davis (2017) Provide
Systematic
update of 2007
Review
American College of
(N=143)
Critical Care Medicine
to form guidelines for
the newborn and
pediatric age groups
Septic Shock.

2006 - 2014,
neonatal and
pediatric
population,
sepsis tool
monitoring
guidelines

Intervention
vs
Comparison
Older
guidelines
versus newer
guidelines
analyzing
compliance,
earlier
identification,
and earlier
intervention

Lake (2014)
Heart rate
characteristics for
monitoring early
detection of late-onset
neonatal sepsis

2004 - 2010
neonates used
a screening
tool indicator
to monitor
neonatal
sepsis

Compared
data from
prior sepsis
without heart
rate
monitoring to
current data

Paliwoda (2015)
Examine use and
efficacy of early
warning tools (EWTs)

RCT
(N=1489)

Systematic
Review
(N=21)

2004 – 2014
systematic
review,
neonatal

Newly
developed
EWT and
standard

Results

Conclusion

Improved
compliance
reduced hospital
mortality from
4% to 2%.
Improved
mortality with
compliance to
first-hour and
stabilization
guideline
recommendations

Consider
institution—
specific use of
1) a recognition
bundle
containing trigger
tool for rapid
identification of
patients with
septic shock,
2) resuscitation
and stabilization
bundle to help
adherence to best
practice
principles 3)
performance
bundle to identify
and overcome
perceived
barriers to best
practice
Heart rate
characteristics
monitoring is
validated risk
marker for sepsis
in the NICU

Predictive value
affirmed good
calibration,
(increase of
0.03), continuous
net
reclassification
index (0.39) and
integrated
discrimination
index (0.01)
Compares well to
other risk factors
Of the 19 infants
who received an
intervention, nine
were identified

There is a need
for validity and
effectiveness of
use of EWTs in

FINAL DEFENSE
in identifications of
deterioration in
neonates.

Roney (2015)
Evaluate current
research on modified
early warning scoring
(MEWS) system tools
to prevent failure to
rescue in hospitalized
adult medicalsurgical/telemetry
patient.

Systematic
Review
(N=18)

44
population,
used a
screening tool
to monitor
neonatal
deterioration
Literature
prior to 2014,
systematic
review, adult
screening
tools
monitoring
sepsis

observation
tool in
identifying
early
deterioration
of neonates
MEWS versus
other
standardized
screening
tools

using EWT
(47%)

neonatal
population

6 of 18 (33%)
reported
mortality
predictive value
and/or reduction,
3 (17%)
measured impact
on emergency
calls, and 4
(39%) reported
impact on
mortality and
rapid response
team utilization

Development of
all-cause illness
screening tools,
including sepsis,
needed.

Clinical picture,
when with
scoring tools,
may assist
clinical decisionmaking leading
to improved
outcomes and
decreased failure
to rescue
Appendix F. Articles included in review with author, year, purpose, design, inclusion, results,
conclusions.
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Appendix G

Appendix G. Center for Disease Control and Prevention’s Infectious Disease Framework (CDC,
2011). Retrieved from https://www.cdc.gov/oid/docs/ID-Framework.pdf
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Appendix H

Administrative approval to conduct this project at the project organization
Appendix H. Available upon request.
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Appendix I

Appendix I. Institute for Healthcare Improvement’s Plan Do Study Act Implementation Model
(IHI, 2017). Retrieved from
http://www.ihi.org/resources/Pages/Tools/PlanDoStudyActWorksheet.aspx
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Appendix J

Item
Did patient go
to ICU?

System

Pediatric
patient

Time to ICU
Time to
antibiotic
initiation
Time to fluid
bolus
Time to
“trigger” tool
Time to sepsis
huddle
Tachycardia*
Bradycardia*
Hypotension*
Fever*
Hypothermia
Current use of
Steroids
Altered Mental
Status
Chills
Capillary Refill
> 3 seconds
Mottled cool
extremities

Measurement
Level
Yes, No
(Categorical)
Minutes
(Numeric)
Minutes
(Numeric)

How Time
Measured/Assessed
Time (Military)

Minutes
(Numeric)
Minutes
(Numeric)

Time (Military)

Minutes
(Numeric)
Numeric
Numeric
Numeric
Yes, No
(Categorical)
Yes, No
(Categorical)
Yes, No
(Categorical)
Yes, No
(Categorical)
Yes, No
(Categorical)
Yes, No
(Categorical)
Yes, No
(Categorical)
Yes, No
(Categorical)
Yes, No
(Categorical)

Time (Military)

Time (Military)
Time (Military)

Time (Military)

Time (Military)
Time (Military)
Time (Military)
Time (Military)
Time (Military)
Time (Military)
Time (Military)
Time (Military)
Time (Military)
Time (Military)

Time (Military)
Neck Stiffness
"Flash"
Time (Military)
Capillary Refill
< 1 second
Neutropenia
Yes, No
Time (Military)
(ANC <500)
(Categorical)
Appendix J. Table of Measures. *See Appendix K. **See Appendix L.

When
Measured/Assessed
After sepsis diagnosis
occurred
From when sepsis was
declared from tool
From when sepsis was
declared from tool
From when sepsis was
declared from tool
From admission to
when sepsis was
declared from tool
From when sepsis was
declared from tool

At time of SEPSIS
Huddle**
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Appendix K

Appendix K. Organization’s definition of hypotension, tachycardia, and bradycardia to inform
completing of screening tool for sepsis
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Appendix L

Presence of
tachycardia,
bradycardia, OR
hypotension
Yes
Presence of fever,
hypothermia, OR
current use of steroids
Yes
Presence of hypotension, altered mental
status, chills, capillary refill greater than 3
seconds, mottled cool extremities, neck
stiffness, OR “flash” capillary refill less
than 1 second
Yes
Sepsis huddle initiated,
and time is recorded
on the sepsis screening
paper tool
Appendix L. Triggers for a sepsis huddle at project organization.
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Appendix M

Pediatric Sepsis Screening Factor:

Evidence to Support in Literature:

Tachycardia

Davis (2017); Randolph (2014)

Bradycardia

Davis (2017); Randolph (2014); Dellinger (2013)

Hypotension

Davis (2017); Randolph (2014); Dellinger (2013)

Fever

Davis (2017); Randolph (2014); Dellinger (2013)

Hypothermia

Davis (2017); Randolph (2014); Dellinger (2013)

Current use of Steroids

Dellinger (2013)

Altered Mental Status

Davis (2017); Sepanski (2014); Dellinger (2013)

Chills

CDC (2017); NHS UK (2016)

Capillary Refill > 3 seconds

Davis (2017); Sepanski (2014)

Mottled cool extremities

Dellinger (2013)

Neck Stiffness

CDC (2017); NHS UK (2016)

"Flash" Capillary Refill < 1 second

Dellinger (2013)

Neutropenia (ANC <500)

Sano (2017)

Appendix M. Evidence to support factors within the pediatric sepsis screening tool at CHM
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Appendix N
Budget

Doctor of Nursing Practice Project Financial Operating Plan
Sepsis Screening Tool Assessment at a Freestanding Children’s Hospital in the Midwest
Revenue
Project Manager Time (in-kind donation)
Consultations
Statistician (in-kind donation)
Cost mitigation
Prevention of 1 case of Severe Sepsis-related ventilator care / per year
Prevention of 1 case of Severe Sepsis that required a ventilator for < 96 hours / per year
TOTAL INCOME
Expenses
Project Manager Time (in-kind donation)
Team Member Time:
Clinical Nurse Specialist (1)
Registered Nurse (1)
Consultations
Statistician (in-kind donation)
Laptop
Cost of print/copy/fax
TOTAL EXPENSES
Net Operating Plan
*O’Brien & CDC. (2015). The cost of sepsis. Retrieved from
https://blogs.cdc.gov/safehealthcare/the-cost-of-sepsis/

6,200.00
100.00
40,878*
11, 794*
58,972.00

6,200.00
2,000.00
3,500.00
100.00
1,200.00
3,672.00
16,672.00
42,300.00
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Appendix O
Timeline
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Appendix P

Characteristic
Mean (SD) range
Age
7.05 (6.05) 0.02-20.57
% (n)
Gender
Female 44.3% (74)
Male 55.7% (93)
Race
Caucasian 60.5% (101)
African American 16.2% (27)
Other 17.4% (29)
Not Documented 6% (10)
Ethnicity
Hispanic 13.8% (23)
Non-Hispanic 79% (132)
Not Documented 7.2% (12)
Hospital Acquired Sepsis
Yes 6% (10)
No 94% (157)
Median (IQR)
Length of stay
10.05 (4.94 –19.14)
Appendix P. Age, gender, race, ethnicity, and length of stay of patients in audit
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Appendix Q

Audit of clinically derived
Tool flagged % (n)
time zero
Before
10.8% (18)
At
24.0% (40)
After
65.3% (109)

Percentage Tool Flagged Before, At, and After CDTZ
70.0%
65.3%

60.0%
50.0%
40.0%
30.0%
20.0%
10.0%

24.0%
10.8%

0.0%
Before

At

After

Appendix Q. Clinical status flagged before, at, and after clinically derived times zero overall
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Appendix R

High risk factor
Yes
42.5% (71)
40.1% (67)

No
54.5% (91)
16.2% (27)

% (n)
Not documented/unclear
3% (5)
43.7% (73)

CNS dysfunction
Leukopenia, Leukocytosis, or
Bands >10%
in the last 12 hours
Central Line
28.7% (48) 42.5% (71)
28.7% (48)
Immunodeficiency
19.8% (33) 21.6% (36)
58.7% (98)
Malignancy
15.6% (26) 84.4% (141)
Patient ≤ 60 days old
9.6% (16)
90.4% (151) Bone Marrow or Solid Organ
7.8% (13)
1.8% (3)
90.4% (151)
Transplant
Asplenia
1.20% (2)
98.8% (165)
Appendix R. High risk factor frequency occurrence documented in health record
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Appendix S

Clinical problem
Median (IQR) n
Neutropenia (ANC <500)
35.57 (0.0 – 717.42) 47
Appendix S. Abnormal high-risk condition clinical problems
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Appendix T
Median (IQR)

Time (hours)
To ICU
To antibiotic
To fluid

Before
4.92 (1.30 – 12.0)
1.47 (0.35 – 5.37)
1.33 (0.02 – 121.8)

Overall

-0.65 (23.72)

After
2.68 (1.58 – 6.30)
1.76 (0.78 – 4.45)
1.16 (0.47 – 2.70)
Mean (SD)
1.35 (6.42)

Difference
2.24
-0.29
0.17
p-Value
0.19

Median Time from CDTZ to ICU, ABX, and Fluid initiation Before
and After Tool Implementation
6
5

4.92

Hours

4
3

2.68

2

1.47

1.76

1.33

1.16

1
0
To ICU

To antibiotic
Before

After

Appendix T. Time from status change to ICU admission, antibiotic, and fluid

To fluid
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Appendix U

Status

% (n)
Yes

No

Tachycardia
65.3% (109)
31.7% (53)
Fever
62.9% (105)
27.0% (45)
Altered Mental Status
38.9% (65)
32.9% (55)
Capillary Refill >3
18.6% (31)
42.5% (71)
seconds
Hypothermia
18.0% (30)
71.9% (120)
Mottled/Cool
16.8% (28) 2.4% (4) 3.6% (6) 44.9% (75)
Extremities
cool
mottled
both
Neutropenia
11.4% (19)
16.2% (27)
Hypotension
9% (15)
70% (117)
Currently on Steroids
8.4% (14)
41.9% (70)
Chills
8.4% (14)
8.4% (14)
Neutropenia
2.4% (4)
17.4% (29)
(ANC <500) >7 days
Neck Stiffness
0.6% (1)
71.3% (119)
Flash Capillary Refill
57.5% (96)
<1 second
Bradycardia
0.6% (1)
96.2% (161)*
*4 of 161 patients or 2.4% of the 96.2% were above the age range

Clinical Status Symptom/Sign That Flagged The Tool
Overall
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rre ion
nt
ly
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…
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00
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a
)
Ne >7
ck day
Fla Stif s
sh fne
Ca ss
Br pilla
ad ry
yc …
ar
di
a

120.0%
100.0%
80.0%
60.0%
40.0%
20.0%
0.0%

Yes

No

Not Documented

Appendix U. Clinical status symptom/sign that flagged the tool

Not
Documented
3.0% (5)
10.2% (17)
28.1% (47)
38.9% (65)
10.2% (17)
32.3% (54)
72.5% (121)
21.0% (35)
49.7% (83)
83.2% (139)
80.2% (134)
28.1% (47)
42.5% (71)
3.0% (5)
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Appendix V

Age groups
Heartrate
0 – 1 Months 181.9 (24.0) 7
>1 – 2 Months 178.8 (36.1) 9
3 – 11 Months 154.2 (30.0) 13
1 – 3 Years
4 – 11 Years
>12 Years

176.0 (28.3) 44
137.5 (35.0) 47
127.6 (26.5) 42

Mean (SD) n
Fever
Systolic
36.2 (1.7) 8
95.3 (20.2) 4
36.7 (3.31) 8
91.2 (14.7) 5
95.8 (21.0) 10
39.0 (1.6) 39

Diastolic
58.3 (24.0) 4
53.2 (12.2) 5
51.9 (8.8) 10

95.9 (20.1) 35 53.1 (22.3) 35
99.6 (19.0) 43 54.5 (16.4) 43
106.4 (19.1) 35 56.2 (16.7) 35
Median (IQR)
3-11 Months
39.0 (35.9 – 40.5) 11
4 – 11 Years
38.9 (32.1 – 39.5) 47
>12 Years
38.8 (33.7 – 40.2) 37
Appendix V. For patients in age range
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Appendix W

High-Risk Factor or Status

% (n)
Yes

No

Not
Documented

Tachycardia
Fever
Altered Mental Status
CNS dysfunction
Central Line
Capillary Refill >3 seconds

84.5% (49)
79.3% (46)
65.5% (38)
51.7% (30)
36.3% (21)
29.3% (17)

15.5% (9)
20.7% (12)
24.1% (14)
46.6% (27)
41.4% (24)
41.4% (24)

10.3% (6)
1.7% (1)
22.4% (13)
29.3% (17)

Leukopenia, Leukocytosis, or
Bands >10%
in the last 12 hours
Hypotension
Hypothermia
Malignancy
Immunodeficiency
Neutropenia
Bone Marrow or Solid Organ
Transplant
Currently on Steroids
Chills
Patient ≤ 60 days old
Neutropenia
(ANC <500) >7 days
Mottled/Cool Extremities

25.9% (15)

27.6% (16)

46.6% (27)

24.1% (14)
20.7% (12)
19% (11)
19% (11)
15.5% (9)
12.1% (7)

53.5% (31)
79.3% (46)
19% (11)
8.6% (5)
3.5% (2)

22.4% (14)
81.0% (47)
62.1% (36)
75.9% (44)
84.5% (49)

10.3% (6)
10.3% (6)
6.9% (4)
5.2% (3)

37.9% (22)
6.9% (4)
93.1% (54)
8.6% (5)

51.7% (30)
82.8% (48)
86.2% (50)

Both 5.2% (3)
Cool 27.6% (16)
Mottled 5.2% (3)
1.7% (1)
1.7% (1)

44.8% (26)

17.2% (10)

74.1% (43)
93.1% (54)

24.1% (14)
-

5.2% (3) Above
age range
69.0% (40)

31.0% (18)

Neck Stiffness
Bradycardia

Flash Capillary Refill <1 second

-

Asplenia
100% (58)
Appendix W. Percentage of factors that flagged tool before or at clinically derived time zero
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Appendix X

Percentage of Factors That Flagged Tool Before or At Clinically
Derived Time Zero

120.0%

100.0%

80.0%

60.0%

40.0%

20.0%

0.0%

Yes
No
Not Documented

Appendix X. Percentage of factors that flagged tool before or at clinically derived time zero
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Objectives for Presentation
1. Present the clinical problem within the
context of the organizational assessment
2. Review evidence supporting solution
3. Review the QI project and results
4. Discuss project sustainability and
dissemination
5. Reflect on DNP Essentials

Introduction
• Sepsis is a major contributor to morbidity and
mortality (Schlapbach & Kissoon, 2018).
• The prevalence of pediatric severe sepsis in
critically ill patients is 8.2% globally, with a
hospital mortality rate of 25% (Weiss et al.,
2015).

Introduction
• Tools for predicting sepsis in pediatrics:
– Poor predictive ability
– Not validated
• (Schlapbach & Kissoon, 2018).

• Systemic inflammatory response syndrome (SIRS) used to
define and predict sepsis in pediatrics.
– Criterion had low specificity
– Limited use to clinicians
• (Schlapbach & Kissoon, 2018).

• An evidence-based pediatric sepsis screening tool is needed
– To initiate early diagnosis
– To treat earlier

Assessment of Organization
• Systematic process to evaluate the workflow
and factors that affect organizational
performance (Reflect & Learn, n.d.).
• Purpose of assessment:
– Use a framework to analyze organization.

Framework: The Canadian Foundation for
Healthcare Improvement (CFHI)
Engage front-line
managers and
providers
Promoting
evidence-based
decision-making

Focusing on
population needs

HEALTHCARE
IMPROVEMENT

Creating
supportive policies
and incentives

Engaging patients

Building
organizational
capacity

(CFHI, 2014)

IRB Approvals
Site IRB available upon request.

Stakeholders
• Site mentors
• Healthcare providers i.e., physicians, physician
assistants, nurse practitioners, and nurses
• Patients
• Sepsis Steering Committee
• Electronic health record technical employees
• Organization

SWOT
•
•
•
•
•

•
•
•

Strengths
Interprofessional Collaboration
Sepsis Steering Committee
Collaboration with CHA
Collaboration within the organization of
CHM in other populations (i.e. adult and
neonatal)
Best Children’s Hospital in 6 specialty
areas for 2018

Opportunities
CHA sepsis collaborative
Working alongside new EHR to
implement a clinical decision support tool
within the EHR
Customization options within the new
EHR

•
•
•
•
•

•
•
•

Weaknesses
Current paper screening tool
Tension with RNs over adding another
task
Collating paper documents in order to
generate reports
Inaccurate timestamp on paper tool
RN confusion and increased errors related
to many changes occurring at once

Threats
Deadlines within CHA collaborative
Difficulty retrieving data from old EHR at
CHM
Current lack of evidence to support a
pediatric sepsis screening tool

Clinical Practice Questions
1. “Did the current pediatric sepsis screening
tool in use at CHM identify patients at risk for
sepsis?”
2. “Did the sepsis screening tool use initiate
intervention (i.e. fluid boluses and antibiotics)
sooner than when compared to no tool?”

Literature Review
• Purpose: Examine tools that identify pediatric
sepsis.
• Aim: Answer the questions:
– “Will a sepsis screening tool adequately aid in
early identification of pediatric sepsis?”
– “What are the specific constructs needed for a
pediatric sepsis screening tool?”
– “Is there evidence to support use of a pediatric
sepsis screening tool?”

Review Method
• CINAHL, PubMed, Web of Science search:
– English in 2013 to 2018.

• Keywords:
–
–
–
–

Sepsis
Tool
Pediatric, neonate, and child
Early warning score.

• Inclusion Criteria:
– Meta analyses, randomized control trials (RCT), and
systematic reviews
– Peer-reviewed journals

Results: Literature Review
• Four papers met inclusion criteria.
– Three systematic reviews
– One RCT.

• Analyzed screening: earlier detection of sepsis.
– One examined heart rate activity in neonatal infants as
a marker for neonatal sepsis
• (Lake, Fairchild, & Moorman, 2014).

– Three reviewed sepsis protocol screening tools for
neonatal, pediatric, and adult populations
• (Davis et al., 2017; Roney et al., 2015; Paliwoda & New,
2015).

Articles identified using
keywords in CINAHL,
PubMed, and Web of
Science (N=243)

Eligibility

# of records screened
after 9 duplicates were
removed (n=234)

Full-text articles
assessed for eligibility
(n=20)

Included

Screening

Identification

PRISMA Figure

Studies included in
this review (n=4)

Records excluded after
title and abstract
reviewed due to not
published in the past 5
years or article not
directly related to sepsis
screening (n=214)
Full-text articles
excluded for reasons
pertaining to population,
intervention,
comparison, and
outcome (n=16)

(Moher et al., 2015)

Summary of Evidence
• Davis (2017) – a bundle containing trigger of tool
for rapid identification of patients with sepsis
• Lake (2014) – Heart rate monitoring a validated
risk marker for sepsis
• Paliwoda (2015) – Need for validity of sepsis
screening tools
• Roney (2015) – Development of sepsis screening
tool needed to improved outcomes

Results: Literature Review
• Evidence supports use of sepsis screening tool
• Designed for pediatric population
– Gold standard for clinical practice
– In the acute care hospital setting.

• Use of tool has the potential to:
– Improve patient outcomes
– Reduce mortality rates.

Evidence for Project
• Use of a screening tool for identification of sepsis and
initiation of interventions improves patient outcomes.
• Factors included in tool:
–
–
–
–
–
–

Respiratory rate
Heart rate
Blood pressure
Temperature (hypothermia or hyperthermia)
Altered mental status
Capillary refill
• (Davis et al., 2017; & Roney et al., 2015).

Model to Examine Phenomenon: CDC’s
Infectious Disease Framework (IDF)
Element 1.
Strengthen public
health
fundamentals,
including infectious
disease surveillance,
laboratory
detection, and
epidemiologic
investigation.

Element 2.
Identify and
implement highimpact public
health
interventions to
reduce infectious
diseases.

(CDC, 2011)

Element 3.
Develop
advanced
policies to
prevent, detect,
and control
infectious
diseases.

Project Plan

Project Purpose & Objectives
Purpose: Detect pediatric sepsis using a
screening tool.
– Current tool had expert review/content validity.
– Tool needed construct validity

Objectives:
1. Examined if tool detected sepsis when compared
to before the tool was implemented
2. Examined time to intervention with tool
compared to no tool

Design
• Quality Improvement project
– Validate a sepsis risk assessment tool

• The project:
1. Examined a cohort of patients diagnosed with
severe sepsis prior to use of the tool.
2. Evaluated if the tool identified risk for sepsis
prior to the sepsis diagnosis occurring.
3. Time to interventions (fluid boluses,
antibiotics) was examined comparing those
who used screening tool to those who did not
use the tool.

Setting & Participants
• Setting:
– Freestanding children’s hospital
– Midwest (CHM)
– Units: hematology, oncology, cardiology,
respiratory, surgical, and behavioral health

• Participants:
– Patients with severe sepsis diagnosis

Implementation Model

(IHI, 2017)

Implementation Strategy #1
Readiness and Identifying Barriers

• Organizational Assessment and SWOT
• Discovered strategies for project:
•
•
•
•

Capturing and sharing knowledge
Creating a learning collaborative
Organizing implementation team meetings
Using an implementation advisor
• (Powell et al., 2015)

Implementation Strategy #2
Capturing and Sharing Knowledge Creating a
Learning Collaborative

• CHM is part of sepsis collaborative
• Children’s Hospital Association (CHA).
• Goal: reduce hospital-acquired severe sepsis and sepsis
mortality by 75% by the year 2020 (CHA, 2018).

• By joining this collaborative:
• CHM part of all-teach, all-learn interdisciplinary team
• Allowed to view research of what other hospitals are
doing to see what works.

Implementation Strategy #3
Organizing Implementation Team Meetings &
Using an Implementation Advisor

• CHM created a sepsis steering committee
– Driving force for organization
– Appointed an implementation advisor to direct the
group meetings

Implementation Strategy #4
Re-Examination & Ongoing Consultation

• Purposely re-examined implementation:
– Of risk-assessment tool
– CHM initially implemented the risk assessment
tool without first ensuring it was evidence-based.

• Provided ongoing consultation with CHM
– Findings in literature
– Results of chart audits
– Results of risk assessment tool validation.

Implementation Strategy #5:
Develop Tools for Quality Monitoring

• Developed tools for quality monitoring
– Measures/codebook for chart audits.

• Distributed to CHM
– After project completion
– For use in
• Organization
• Collaborative

Evaluation & Measures
Measurement Level

How Time Measured/Assessed

When Measured/Assessed

Item
Yes, No (Categorical)

Time (Military)

After sepsis diagnosis occurred

Minutes (Numeric)

Time (Military)

From when sepsis was declared
from tool

Minutes (Numeric)

Time (Military)

From when sepsis was declared
from tool

Minutes (Numeric)

Time (Military)

From when sepsis was declared
from tool

Minutes (Numeric)

Time (Military)

From admission to when sepsis
was declared from tool

Minutes (Numeric)

Time (Military)

From when sepsis was declared
from tool

Numeric
Numeric
Numeric
Yes, No (Categorical)
Yes, No (Categorical)
Yes, No (Categorical)
Yes, No (Categorical)
Yes, No (Categorical)
Yes, No (Categorical)

Time (Military)
Time (Military)
Time (Military)
Time (Military)
Time (Military)
Time (Military)
Time (Military)
Time (Military)
Time (Military)

Yes, No (Categorical)

Time (Military)

Yes, No (Categorical)
Yes, No (Categorical)

Time (Military)
Time (Military)

Yes, No (Categorical)

Time (Military)

Did patient go to ICU?
Time to ICU
System

Time to antibiotic initiation
Time to fluid bolus

Time to “trigger” tool

Pediatric patient

Time to sepsis huddle
Tachycardia*
Bradycardia*
Hypotension*
Fever*
Hypothermia
Current use of Steroids
Altered Mental Status
Chills
Capillary Refill > 3 seconds
Mottled cool extremities
Neck Stiffness
"Flash" Capillary Refill < 1
second
Neutropenia (ANC <500)

At time of SEPSIS Huddle**

Evaluation & Measures

Analysis Plan
• Compare pre-/post-tool audit
– Patients with severe sepsis diagnoses.

• Before use of the screening tool:
– When fluid boluses and antibiotics were given
– Recorded vital signs to see if sepsis would have been
identified sooner based on the items the tool evaluates.
– Measure when sepsis was diagnosed
– How long before a patient with sepsis went to ICU

• Patients identified for sepsis by the screening tool
– Used to compare time to sepsis diagnosis
– Between pre-/post patients

Timeline

Characteristic
Age
Gender
Race

Results
Ethnicity

Hospital Acquired
Sepsis
Length of stay

Mean (SD) range
7.05 (6.05) 0.02-20.57
% (n)
Female 44.3% (74)
Male 55.7% (93)
Caucasian 60.5% (101)
African American 16.2% (27)
Other 17.4% (29)
Not Documented 6% (10)
Hispanic 13.8% (23)
Non-Hispanic 79% (132)
Not Documented 7.2% (12)
Yes 6% (10)
No 94% (157)
Median (IQR)
10.05 (4.94 –19.14)

Results
Percentage Tool Flagged Before, At, and After CDTZ
70.0%
65.3%
60.0%

50.0%

40.0%

30.0%

24.0%

20.0%

10.0%

10.8%

0.0%
Before

At

After

Results
High risk factor

% (n)
Yes

No

Not documented/unclear

CNS dysfunction

42.5% (71)

54.5% (91)

3% (5)

Leukopenia, Leukocytosis, or
Bands >10%
in the last 12 hours

40.1% (67)

16.2% (27)

43.7% (73)

Central Line

28.7% (48)

42.5% (71)

28.7% (48)

Immunodeficiency

19.8% (33)

21.6% (36)

58.7% (98)

Malignancy

15.6% (26)

-

84.4% (141)

Patient ≤ 60 days old

9.6% (16)

90.4% (151)

-

Bone Marrow or Solid Organ
Transplant

7.8% (13)

1.8% (3)

90.4% (151)

Asplenia

1.20% (2)

-

98.8% (165)

Results
Clinical problem
Neutropenia (ANC <500)

Median (IQR)
N = 47
35.57
(0.0 – 717.42)
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*4 of 161 patients or 2.4% of the 96.2% were above the age range

Clinical Status Symptom/Sign That Flagged The Tool Overall
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Results
Age groups

Mean (SD) n
Heartrate

Fever

Systolic

Diastolic

0 – 1 Months

181.9 (24.0) 7

36.2 (1.7) 8

95.3 (20.2) 4

58.3 (24.0) 4

>1 – 2 Months

178.8 (36.1) 9

36.7 (3.31) 8

91.2 (14.7) 5

53.2 (12.2) 5

3 – 11 Months

154.2 (30.0) 13

95.8 (21.0) 10

51.9 (8.8) 10

1 – 3 Years

176.0 (28.3) 44

95.9 (20.1) 35

53.1 (22.3) 35

4 – 11 Years

137.5 (35.0) 47

99.6 (19.0) 43

54.5 (16.4) 43

>12 Years

127.6 (26.5) 42

106.4 (19.1) 35

56.2 (16.7) 35

39.0 (1.6) 39

Median (IQR)
3-11 Months

39.0 (35.9 – 40.5) 11

4 – 11 Years

38.9 (32.1 – 39.5) 47

>12 Years

38.8 (33.7 – 40.2) 37
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Percentage of Factors That Flagged Tool Before or At Clinically Derived Time Zero
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Discussion
• Project found that the current tool use at CHM to detect risk
of sepsis needs further testing of validity and reliabilty.
• Supported by the current state of the literature:
– No evidence-based sepsis screening tools are tailored for
pediatric populations
– Only content-reviewed factors to screen for when evaluating for
sepsis in pediatrics
– (Davis et al., 2017; Lake, Fairchild, & Moorman, 2014;
Paliwoda & New, 2015 & Roney et al., 2015).

• Creation and testing of a tool to detect risk of Sepsis is
needed before a tool will be validated for evidence-based
use.

Key Findings
• This is a much-needed area of study à any
research findings to add to the current state of
literature aid in shaping a future tool validation.
• A decrease in median time to ICU transfer and
fluid bolus initiation were found when comparing
pre- to post- tool implementation.
–

This shows an improvement in a critical timesensitive component of treating sepsis that is
dependent on initially detecting sepsis through a
screening tool.

Key Findings
• This study spoke to what the top clinical status
signs/symptoms were in severe sepsis patients,
– This is useful information when deciding where to go
next in configuring a tool that has construct validity.

• Finally, this project also was able to evaluate agespecific parameters for clinical status
signs/symptoms such as heart rate, fever, and
blood pressure.
– This information is also useful when determining next
steps for a sepsis screening tool and could be used in
future research.

Limitations
• This project had a fairly short implementation period and
small sample size.
– Although 20 months of data were used, there were still only 167
patients that met criteria of a severe sepsis diagnosis included in
this project.
– Due to this, SEM analysis was not able to be performed, which
could have been an advantageous statistical analysis to run for
this type of project.

• Relatively small sample size of post-tool implementation
patients (n=45).
– Time constraints for data collection
– Not enough collated data on severe sepsis diagnosed patients

• Lack of current evidence in literature to support any
pediatric sepsis screening tool, let alone this specific tool.

Implications for Practice
• Top five clinical status that flagged the tool
– Tachycardia, fever, altered mental status, capillary
refill in greater than 3 seconds, and hypothermia.
– Most useful in identifying pediatric sepsis

• Other factors may need to be considered
– Both systolic and diastolic blood pressure values
– Respirations
– Peripheral capillary oxygen saturation (Sp02)

• Consider combining risk assessment tools in
the pediatric population into one cohesive tool

Conclusions
• CHM sought to validate a sepsis screening tool
currently in use for evidence-based use.
• Organizational Assessment and Literature Review
Performed
• Two theoretical frameworks and one theoretical model
were used to understand the phenomenon and conduct a
plan to validate the sepsis screening tool.
• Pre- and post-tool chart audits were performed to
implement this tool validation plan.
• Data collection occurred over two months including
patients from January 2017 through August 2018.

Conclusions
• Despite being unable to provide construct
validity for this pediatric sepsis screening tool,
individual factors within the tool were able to
be evaluated and future studies should build
upon this research in order to work towards
validating a pediatric sepsis screening tool for
evidence-based use.

Resources & Budget
Doctor of Nursing Practice Project Financial Operating Plan
Sepsis Screening Tool Assessment at a Freestanding Children’s Hospital in the Midwest
Revenue
Project Manager Time (in-kind donation)
Consultations
Statistician (in-kind donation)
Cost mitigation
Prevention of 1 case of Severe Sepsis-related ventilator care / per year

40,878*

Prevention of 1 case of Severe Sepsis that required a ventilator for < 96 hours / per year
TOTAL INCOME

11, 794*
58,972.00

6,200.00
100.00

Expenses
Project Manager Time (in-kind donation)
Team Member Time:
Clinical Nurse Specialist (1)
Registered Nurse (1)
Consultations
Statistician (in-kind donation)
Laptop
Cost of print/copy/fax
TOTAL EXPENSES

100.00
1,200.00
3,672.00
16,672.00

Net Operating Plan

42,300.00

*(O’Brien & CDC, 2015)

6,200.00
2,000.00
3,500.00

Sustainability Plan
• Sepsis steering committee chair
– Monitor the effectiveness of the screening tool.

• Sepsis screening tool was embedded in EHR.
– January 3, 2019
– Made for easier monitoring:
• Tool effectiveness
• Sepsis detection.

Dissemination
1) Tools for quality monitoring (table of measures and
codebook used to conduct chart audits) and findings
were distributed to CHM for use within the
organization and collaborative.
2) Findings presented at the student’s oral defense on
April 8, 2019.
3) Final project defense paper posted on Scholarworks
4) Findings will be presented at the organization’s
research council poster presentation on April 9, 2019
5) Findings will be presented to the sepsis steering
committee at the May 6, 2019 meeting

The American Colleges of Nursing (AACN)
requires proficiency from DNP students in the
following 8 competencies which make up the
foundation for advanced practice nursing roles.

Each are reviewed on the following slides.

DNP Essentials Reflection
• Essential I: Scientific Underpinnings for Practice
– This essential was achieved through this project by performing a
literature review and using the knowledge gained from this
review to improve care.
– Additionally, frameworks were utilized for implementing and
guiding change.

• Essential II: Organizational and Systems Leadership
– This essential was achieved through this project by evaluating a
tool that enhances care provided to the pediatric population.
– Furthermore, developing and evaluating cost-effectiveness is
another aspect of this essential that was met by developing a
budget for this project and monitoring the project’s cost
effectiveness

DNP Essentials Reflection
• Essential III: Clinical Scholarship and Analytical Methods for
Evidence-Based Practice
– This essential was achieved through this project by using analytic
methods to evaluate literature regarding the best evidence for sepsis
screening in pediatric populations.
– The project included designing a process to evaluate the effectiveness
of the current sepsis screening tool in place.
– Furthermore, relevant findings were disseminated to improve practice
guidelines for use of the tool.

• Essential IV: Information Systems Technology
– This essential was met by utilizing and navigating two different EHRs
to gather pre- and post-tool data. E-mail was used for communication
with key stakeholders for progress updates and additional resources.
– Excel was used for organizing and analyzing data.
– Strict confidentiality of any identifiable patient data was maintained,
and all ethical guidelines were followed during the course of this
project.

DNP Essentials Reflection
• Essential V: Advocacy for Health Care Policy
– Although no formal policy was changed through this project, education
and advocacy for implementation of evidence-based policies at an
organizational level were performed through this project.
– Additionally, this essential was met through attendance of Advocacy
Day and meeting with state legislatures regarding policies that advocate
for the expansion of the advanced practice registered nurse role.

• Essential VI: Interprofessional Collaboration
– This essential was met through collaborating with multiple different
healthcare roles in the development, implementation, and evaluation of
this project.
– Collaborative healthcare professionals included RNs, managers, CNSs,
educators, pharmacists, providers, IT/quality improvement data
specialists, and statisticians.
– Incorporating a diverse collaborative group allowed for better
understanding of the current practice, assessing barriers, and evaluating
necessary practice changes.

DNP Essentials Reflection
• Essential VII: Clinical Prevention and Population Health
– This project was focused on prevention for better population health.
– Sepsis is a leading cause of hospital-related deaths – this not only causes
poor patient outcomes but also costs both the patient and the healthcare
system substantial amounts of money.
– Validating a tool in use to ensure it is actually detecting sepsis rates
sooner allows the hospital to evaluate how well they are doing with
detecting and treating sepsis in their patients.

• Essential VIII: Advanced Nursing Practice
– This essential encompasses the competencies that are necessary for all
DNP-prepared specialties and act as a foundation for DNP practice.
– An organizational assessment of current practice was performed and
systems thinking was used to design and implement a plan to evaluate the
sepsis screening tool for evidence-based use.
– In order to carry out this project, many relationships with various
stakeholders, primarily consisting of the sepsis steering committee
members, were developed and sustained
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